NanotheraNostics Research Group (N2)

Our research group was established to explore a unique and "unfamiliar" field within the Pharma community that combines two distinct fields namely therapeutics and diagnostics (theranostics). 

With the rapid and inevitable growth of nanomaterial synthesis, we are interested in "integrating" these materials into therapeutic agents and diagnostic devices. Our research interests include, but are not limited to low-dimensional nanomaterials, nanosensors, advanced diagnostics, biodevices, microPADs, nanotherapeutics, corona proteins, first-principle calculations, and in silico studies (docking, MDs).

Just as N2 (nitrogen) gas occupies most of the air composition (up to 78%) to support our daily lives, we hope this young and dynamic group can make greater contributions to the pharmaceutical, medical, and healthcare communities nationally and globally.